11 May 2026
REAC® technology and Alzheimer's disease: a controlled clinical trial on motor effects
A randomized cross-over study evaluates the feasibility, safety and motor effects of the REAC® NPO protocol in 60 patients.
News
Published studies, congresses and updates on REAC® Technology and ASMED® devices.
11 May 2026
A randomized cross-over study evaluates the feasibility, safety and motor effects of the REAC® NPO protocol in 60 patients.
15 September 2025
Analysis of the Lombardi et al. (2025) study on REAC NPO and NMO protocols in early functional recovery after stroke.
Reserved access
Access to the display of medical devices and information material is reserved for operators in the sector, in compliance with current legislation.
By continuing to browse, I declare that I am a healthcare professional.
EnterFor information on treatments you can contact the Rinaldi Fontani Institute in Florence.
Go to irf.itLegislative Decree No 46 of 24 February 1997 — Article 21